Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Association of NOD1 and NOD2 polymorphisms with Guillain-Barré syndrome in Northern Indian population.
Confronting the diagnosis of multiple sclerosis: a qualitative study of patient experiences.
Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve
Safety, tolerability, and efficacy of orally administered cannabinoids in MS.
Neuronal antigens recognized by cerebrospinal fluid IgM in multiple sclerosis.
Association of IL4 and IL4R polymorphisms with multiple sclerosis susceptibility in Caucasian population: A meta-analysis.
Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.
Outcome and survival of asymptomatic PML in natalizumab-treated MS patients.
Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS.
Study shows promising efficacy for peginterferon beta-1a in multiple sclerosis
Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis (PROMESS)
Optic neuritis in a child with biotinidase deficiency: case report and literature review.
Progressive multiple sclerosis: The treatment gap.
Proton Density MRI Increases Detection of Cervical Spinal Cord Multiple Sclerosis Lesions Compared with T2-Weighted Fast Spin-Echo.
Treating multiple sclerosis with monoclonal antibodies: a 2013 update.
Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset.
Transcriptional enhancers: from properties to genome-wide predictions.
Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.
Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome.
The "liberation procedure" for multiple sclerosis: sacrificing science at the altar of consumer demand.
Association between apolipoprotein E gene polymorphism and the risk of multiple sclerosis: A meta-analysis of 6977 subjects.
Symptom overlap in anxiety and multiple sclerosis.
Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning.
Immunohistochemical detection of sphingosine-1-phosphate and sphingosine kinase-1 in human tissue samples.
Platelets provide a bounty of potential targets for therapy in multiple sclerosis.

Pages